Scientists studying COVID-19 evolution found that human proteins may be driving the virus’s mutations as a defense mechanism, but natural selection helps it adapt. Scientists at the Milner Centre for…
…of strains with as many as six mutational differences from proCoV2 existed at the time of the first detection of COVID-19 cases in China. With estimates of SARS-CoV-2 mutating 25…
…months beyond, meaning the long COVID phase.” Additionally, the study indicated that the risk seems to increase with each infection. “This means that even if you’ve had two COVID-19 infections,…
…Johnson & Johnson — all target spike. And potent anti-spike antibodies were selected for development into antibody-based drugs for COVID-19. Viruses are always mutating, but for nearly a year the…
…host, rather than from the pathogen itself, could offer effective treatment for a range of infectious diseases, including COVID-19. The study, conducted by an international team and led by RMIT…
…hospitalized with COVID-19. Four of those five were fully vaccinated. This means that only 1% of those vaccinated patients who developed COVID-19 were hospitalized. There were no deaths reported. They…
…was detected in August 2023, the JN.1 variant of COVID has spread widely. It has become dominant in Australia and around the world, driving the biggest COVID wave seen in…
…evolve, say scientists. Writing in Nature, a team led by Cambridge researchers report how they were able to observe SARS-CoV-2 mutating in the case of an immunocompromised patient treated with…
…antibodies or vaccines, researchers did not find evidence of such evasion. COVID-19 drugs, vaccines still effective against mutating virus. Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus…
…to support COVID-19 research, with the additional time supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19 with funding provided by the Coronavirus CARES Act….
…an AI-generated vaccine in providing immunity against future COVID-19 variants. Unlike current COVID-19 vaccines, which target the spike protein of the SARS-CoV-2 virus and are prone to losing efficacy due…
…Arizona and Illumina, Inc., estimate that the SARS-CoV-2 virus was likely circulating undetected for at most two months before the first human cases of COVID-19 were described in Wuhan, China…
…broadly protective COVID-19 T cell vaccine. HIV is one of the fastest-mutating viruses known to humankind. But HIV’s ability to mutate isn’t unique among RNA viruses — most viruses develop…
…transmission is a major, or even dominant transmission pathway for most respiratory diseases, not just COVID-19. Rendering of mutating virus cells. Credit: istock.com/wildpixel “Transmission through inhalation of virus-laden aerosols has…
…of the first detection of COVID-19 cases in China. The current major variants of interest including the UK (B.1.1.1.7), South African (B.1.351), South American (P.1) and now, Indian (B.1.617) are…
The new drug may provide a new type of protection against COVID-19, one that will be effective even when new strains emerge. University of Southern California and the Cleveland Clinic…
Scientists have identified a shared molecular feature present in numerous human antibodies that can neutralize SARS-CoV-2, the virus responsible for COVID-1 The findings support many vaccine strategies being used to…
Amino Acid Substitutions on SARS-CoV-2 Spike Protein Argonne computational resources supported the largest comprehensive analysis of COVID-19 genome sequences in the U.S. and helped corroborate growing evidence of a protein…